2024-05-13 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $5.55 | $166,500 | +32.71% | |
2023-02-01 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $10.38 | $1.04M | -31.89% | |
2022-12-15 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $10.90 | $153,690 | -30.48% | |
2022-12-02 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $12.80 | $1.06M | -40.23% | |
2022-01-11 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $15.04 | $2.77M | -22.7% | |
2020-12-15 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $6.24 | $1.67M | +56.02% | |
2019-11-18 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $1.45 | $145,000 | +118.24% | |
2018-12-03 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $5.16 | $825,600 | -61.06% | |
2015-06-19 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $8.11 | $324,400 | -41.64% | |
2012-03-02 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $4.78 | $13,006 | -18.34% | |
2011-08-08 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $2.52 | $25,190 | +42.86% | |
2011-03-18 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $3.40 | $33,988 | -4.36% | |
2009-01-30 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $1.61 | $4,845 | +240.53% | |
2008-12-01 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $1.48 | $81,450 | +241.74% | |
2008-11-03 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $1.75 | $43,729 | +85.17% | |
2008-08-12 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $3.10 | $7,124 | -34.55% | |
2008-08-11 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $2.95 | $22,736 | -31.95% | |
2008-08-04 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $2.82 | $677 | -34.55% | |
2008-01-31 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $3.50 | $10,506 | -30.58% | |
2007-08-14 | Purchase | BioCryst Pharmaceuticals, Inc. BCRX | President & CEO | | $9.86 | $26,129 | -57.75% | |